Wear it pink this October At work. At school. At home. Wherever you do it, wear pink and raise money to fund life-changing research and support
Home About us Media Breast Cancer Now media statements 163 results We respond to NHS Breast Screening Programme Statistics for Scotland 2017/18 to 2019/20 01 Jun 2021 2 min read We respond to NHS England breast cancer waiting times: March 2021 13 May 2021 2 min read We respond to the Clinical Radiology UK Workforce Census 2020 Report from The Royal College of Radiologists 28 Apr 2021 2 min read We welcome the approval of trastuzumab deruxtecan for use on the Cancer Drugs Fund 20 Apr 2021 4 min read We respond to NHS England breast cancer waiting times: February 2021 15 Apr 2021 2 min read We welcome introduction of new treatment method for HER2 positive breast cancer by NHS England 04 Apr 2021 1 min read We respond to new study into early-stage breast cancer treatment in UK during initial months of COVID-19 pandemic 29 Mar 2021 2 min read We respond to a new study about lifestyle and breast cancer risk 25 Mar 2021 1 min read We respond to NHS England breast cancer waiting times: January 2021 15 Mar 2021 3 min read We respond to a study from King's College London into the effectiveness of the Pfizer COVID-19 vaccine for people with cancer 11 Mar 2021 1 min read We welcome NICE approval of ribociclib with fulvestrant for use on the NHS 26 Feb 2021 3 min read We respond to draft NICE decision not to recommend abemaciclib with fulvestrant for routine use on the NHS 12 Feb 2021 3 min read Previous 1 ... 12 ... 14 Next
We respond to NHS Breast Screening Programme Statistics for Scotland 2017/18 to 2019/20 01 Jun 2021 2 min read
We respond to the Clinical Radiology UK Workforce Census 2020 Report from The Royal College of Radiologists 28 Apr 2021 2 min read
We welcome the approval of trastuzumab deruxtecan for use on the Cancer Drugs Fund 20 Apr 2021 4 min read
We welcome introduction of new treatment method for HER2 positive breast cancer by NHS England 04 Apr 2021 1 min read
We respond to new study into early-stage breast cancer treatment in UK during initial months of COVID-19 pandemic 29 Mar 2021 2 min read
We respond to a study from King's College London into the effectiveness of the Pfizer COVID-19 vaccine for people with cancer 11 Mar 2021 1 min read
We respond to draft NICE decision not to recommend abemaciclib with fulvestrant for routine use on the NHS 12 Feb 2021 3 min read